In line with our findings that Neu3 is decreased in islets in T2D, there was marked down-regulation of Neu3 gene expression in the activated PBMCs at both acute and chronic treatments (Fig. 5G,H). The gene discussed is NEU3; the disease is type 2 diabetes mellitus.